NCT03073863View on ClinicalTrials.gov

Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study

PHASE4CompletedINTERVENTIONAL
Enrollment

10,001

Participants

Timeline

Start Date

April 3, 1998

Primary Completion Date

May 1, 2007

Study Completion Date

May 1, 2007

Conditions
Cardiovascular Diseases
Interventions
DRUG

Atorvastatin

Analysis

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Korea University Guro Hospital

OTHER

NCT03073863 - Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study | Biotech Hunter | Biotech Hunter